Investors

Overview

Ra Pharma® is a clinical-stage biopharmaceutical company using a proprietary peptide chemistry platform to develop novel therapeutics for the treatment of serious diseases that are caused by excessive or uncontrolled activation of the complement system, a critical component of the immune system.

Stock Quote

  

Copyright West LLC. Minimum 15 minutes delayed.

Stock Chart

Recent News
Ra Pharmaceuticals Announces Expansion of Neuromuscular Portfolio with Clearance of IND Application for Zilucoplan for the Treatment of Immune-Mediated Necrotizing Myopathy
Read More
Upcoming Events

Contact Us

Ra Pharmaceuticals, Inc.
87 Cambridgepark Drive
Cambridge, MA 02140
Phone: (617) 401-4060
Fax: (617) 401-4061

info@rapharma.com